ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)

HKD 6.4

(17.22%)

Inventory Summary of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest annual inventory in 2023 was 76.76 Million CNY , up 748.93% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s latest quarterly inventory in 2024 Q2 was 68.9 Million CNY , down 0.0% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported annual inventory of 9.04 Million CNY in 2022, down -53.43% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported annual inventory of 19.42 Million CNY in 2021, down 0.0% from previous year.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported quarterly inventory of 68.9 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • ImmuneOnco Biopharmaceuticals (Shanghai) Inc. reported quarterly inventory of 76.76 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Historical Annual Inventory of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2023 - 2021)

Year Inventory Inventory Growth
2023 76.76 Million CNY 748.93%
2022 9.04 Million CNY -53.43%
2021 19.42 Million CNY 0.0%

Peer Inventory Comparison of ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Name Inventory Inventory Difference
Uni-Bio Science Group Limited 36.39 Million HKD -110.95%
CK Life Sciences Int'l., (Holdings) Inc. 1.2 Billion HKD 93.627%